Cedric Francois is President & Chief Executive Officer of Apellis Pharmaceuticals, Inc. (APLS). The company reported total compensation of $10,957,451 for fiscal year 2024.
| Salary | $793,193 |
|---|---|
| Bonus | $580,736 |
| Stock awards | $4,779,832 |
| Option awards | $4,787,768 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $15,922 |
| Total | $10,957,451 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Apellis Pharmaceuticals, Inc. filed April 23, 2025, accession 0000950170-25-056966.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2024 | President & Chief Executive Officer | $793,193 | $580,736 | $4,779,832 | $4,787,768 | $0 | $0 | $15,922 | $10,957,451 |
| FY2023 | President & Chief Executive Officer | $734,539 | $694,688 | $4,394,319 | $4,542,373 | $0 | $0 | $7,130 | $10,373,049 |
| FY2022 | President & Chief Executive Officer | $680,827 | $512,380 | $4,260,590 | $3,744,353 | $0 | $0 | $5,406 | $9,203,556 |
Totals as disclosed in each year's own compensation disclosure for Apellis Pharmaceuticals, Inc..
| Peer-group chief executive median | $13,350,777 |
|---|---|
| Difference from that median | $-2,393,326 |
| Percentile within the disclosed peer group | 38th |
| Peers with a disclosed figure | 13 |
Medians and percentiles are computed across the peer group Apellis Pharmaceuticals, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2024 total |
|---|---|---|
| Cedric Francois this page | President & Chief Executive Officer | $10,957,451 |
| Caroline Baumal | Chief Medical Officer | $4,407,128 |
| Adam Townsend | Chief Commercial Officer | $3,956,053 |
| Timothy Sullivan | Chief Financial Officer | $3,949,075 |
| David Watson | General Counsel | $3,891,721 |
The company's named executive officers for fiscal year 2024, and what it reported for each. See the full Apellis Pharmaceuticals, Inc. compensation brief.
Cedric Francois's compensation sits inside Apellis Pharmaceuticals, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.